<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recombinant human growth hormone is generally safe in treating children with <z:hpo ids='HP_0000824'>growth hormone deficiency</z:hpo> and idiopathic <z:hpo ids='HP_0004322'>short stature</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, side effects such as <z:chebi fb="199" ids="26708">sodium</z:chebi> and water retention, benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0008189'>insulin insensitivity</z:hpo>, increasing risk of secondary <z:hpo ids='HP_0002664'>neoplasm</z:hpo>, <z:hpo ids='HP_0002650'>scoliosis</z:hpo>, and slipped capital femoral epiphysis may occur occasionally, although the overall incidence remains low </plain></SENT>
</text></document>